Note: Descriptions are shown in the official language in which they were submitted.
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
TITLE: USE
OF MEDIUM CHAIN PERACIDS FOR BIOFILM INHIBITION
IN INDUSTRIAL RECIRCULATING WATER SYSTEMS
.. CROSS-REFERENCE TO RELATED APPLICATIONS
This application is related to and claims priority under 35 U.S.C. 119 to
U.S.
Provisional Application Ser. No. 62/562,591,938 filed on September 25, 2017
and entitled
"USE OF MEDIUM CHAIN PERACIDS FOR BIOFILM INHIBITION IN INDUSTRIAL
RECIRCULATING WATER SYSTEMS." The entire contents of this patent application
.. are hereby expressly incorporated herein by reference including, without
limitation, the
specification, tables, examples, claims, and abstract.
FIELD OF THE INVENTION
The invention relates generally to the field of water treatment technologies
and,
more particularly, to methods and compositions for inhibiting biofilm
formation in
commercial and industrial water systems.
BACKGROUND OF THE INVENTION
Water systems are an integral part of process operations in many industries.
For
.. continuous plant productivity, these systems require proper treatment and
preventative
maintenance. In industrial and commercial water systems corrosion, scale,
fouling and
biological contamination are major issues which have to be taken into account
to withstand
significant problems. If not properly controlled, these problems have a
direct, negative
impact on the value of the entire process or operation.
Biofouling has always been problematic in commercial and industrial water
systems, such as cooling tower waters and air washers, because it can
adversely affect heat
transfer efficiency and fluid frictional resistance, thereby subsequently
reducing production
rates. The fouling is caused by a biomass which is the buildup of
microorganisms and/or
extracellular substances and by dirt or debris that become trapped in the
biomass. Bacteria,
fungi, yeasts, diatoms and protozoa are only some of the organisms which cause
buildup of
a biomass. Biofouling is also a problem in pulp and paper mill systems because
the growth
of microorganisms in papermachine fluids can adversely affect finished paper
products,
thereby requiring the papermachine to be shut down, resulting in the loss of
productivity
1
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
brought on by the down time of the machine. Furthermore, biofouling plays an
important
role in microbiologically influenced corrosion.
The presence of microorganisms in commercial and industrial waters cannot be
totally eliminated, even with the excessive use of chemical biocides. The most
common
way to control biofouling is through the application of chemical biocides such
as chlorine
(e.g. hypochlorite), bromine, isothiazolones, glutaraldehyde or other
antimicrobials. The
traditional metric for biocide efficacy in bulk solution systems is kill
against microbes
suspended in solution, so-called planktonic microbes. However, it is the
microbes
agglomerated on surfaces, biofilms, so-called sessile microbes, that
significantly affect the
process and operation of water systems.
Some microorganisms attach to inert surfaces forming aggregates with a complex
matrix consisting of extracellular polymeric substances (EPS). This consortium
of attached
microorganisms and the associated EPS is commonly referred to as a biofilm.
Biocides
have difficulty penetrating biofilms and removing them from surfaces. Although
excessive
biocide dosages may be able to control biofouling, such use is costly.
Accordingly, it is an objective of the claimed invention to develop a method
of
inhibiting biofilm formation in commercial and industrial water systems which
utilizes a
low-cost, non-biocidal substance
A further object of the invention provides compositions effective in
mitigating
and/or preventing planktonic and/or biofilm bacterial growth.
Other objects, advantages and features of the present invention will become
apparent from the following description taken in conjunction with the
accompanying
Examples.
BRIEF SUMMARY OF THE INVENTION
An advantage of the invention is effective management or kill of both
planktonic
and sessile microorganisms in industrial and commercial water systems through
the use of
the peracid compositions described herein. As a result, the peracid
compositions and
methods of employing the same in water systems overcome a significant need in
the art for
improved sanitation methods which reduce or prevent microbe growth in
suspension and
on surfaces, e.g. biofilms. These and other unexpected benefits achieved by
the present
invention are disclosed herein.
2
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
In an aspect of the invention, a method for reducing and/or eliminating
microbial
populations in a water system comprising: applying a peracid composition to
sanitize a
water system, wherein the peracid composition comprises a short chain peracid
and a
medium chain peracid; and reducing and/or eliminating a microbial population
of yield
loss organisms in said fermentation system.
While multiple embodiments are disclosed, still other embodiments of the
present
invention will become apparent to those skilled in the art from the following
detailed
description, which shows and describes illustrative embodiments of the
invention.
Accordingly, the detailed description and its Examples are to be regarded as
illustrative in
nature and not restrictive.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
The present invention relates to sanitizing water systems. The peracid
compositions and methods of employing have many advantages over conventional
biocide
utilized for such systems. For example, the peracid compositions of the
invention are not
only effective in reducing or preventing microbe growth in bulk solution but
also is
effective in reducing or preventing microbe growth on surfaces.
The embodiments of this invention are not limited to particular methods or
peracid
compositions, which can vary and are understood by skilled artisans. It is
further to be
understood that all terminology used herein is for the purpose of describing
particular
embodiments only, and is not intended to be limiting in any manner or scope.
For
example, as used in this specification and the appended claims, the singular
forms "a," "an"
and "the" can include plural referents unless the content clearly indicates
otherwise.
Further, all units, prefixes, and symbols may be denoted in its SI accepted
form.
Numeric ranges recited within the specification are inclusive of the numbers
defining
the range and include each integer within the defined range. Throughout this
disclosure,
various aspects of this invention are presented in a range format. It should
be understood
that the description in range format is merely for convenience and brevity and
should not be
construed as an inflexible limitation on the scope of the invention.
Accordingly, the
description of a range should be considered to have specifically disclosed all
the possible
sub-ranges, fractions, and individual numerical values within that range. For
example,
description of a range such as from 1 to 6 should be considered to have
specifically disclosed
3
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
sub-ranges such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2
to 6, from 3 to
6 etc., as well as individual numbers within that range, for example, 1, 2, 3,
4, 5, and 6, and
decimals and fractions, for example, 1.2, 3.8, P/2, and 43/4 This applies
regardless of the
breadth of the range.
Definitions
So that the present invention may be more readily understood, certain terms
are
first defined. Unless defined otherwise, all technical and scientific terms
used herein have
the same meaning as commonly understood by one of ordinary skill in the art to
which
embodiments of the invention pertain. Many methods and materials similar,
modified, or
equivalent to those described herein can be used in the practice of the
embodiments of the
present invention without undue experimentation, the preferred materials and
methods are
described herein. In describing and claiming the embodiments of the present
invention, the
following terminology will be used in accordance with the definitions set out
below.
The term "about," as used herein, refers to variation in the numerical
quantity that
can occur, for example, through typical measuring techniques and equipment,
with respect
to any quantifiable variable, including, but not limited to, mass, volume,
time, distance,
wave length, frequency, voltage, current, and electromagnetic field. Further,
given solid
and liquid handling procedures used in the real world, there is certain
inadvertent error and
variation that is likely through differences in the manufacture, source, or
purity of the
ingredients used to make the compositions or carry out the methods and the
like. The term
"about" also encompasses amounts that differ due to different equilibrium
conditions for a
composition resulting from a particular initial mixture. The term "about" also
encompasses these variations. Whether or not modified by the term "about," the
claims
include equivalents to the quantities.
The methods and compositions of the present invention may comprise, consist
essentially of, or consist of the components and ingredients of the present
invention as well
as other ingredients described herein. As used herein, "consisting essentially
of' means that
the methods, systems, apparatuses and compositions may include additional
steps,
components or ingredients, but only if the additional steps, components or
ingredients do
not materially alter the basic and novel characteristics of the claimed
methods, systems,
apparatuses, and compositions.
4
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
The term "actives" or "percent actives" or "percent by weight actives" or
"actives
concentration" are used interchangeably herein and refers to the concentration
of those
ingredients involved in cleaning expressed as a percentage minus inert
ingredients such as
water or salts.
As used herein, the term "alkyl" or "alkyl groups" refers to saturated
hydrocarbons
having one or more carbon atoms, including straight-chain alkyl groups (e.g.,
methyl,
ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, etc.),
cyclic alkyl groups (or
"cycloalkyl" or "alicyclic" or "carbocyclic" groups) (e.g., cyclopropyl,
cyclopentyl,
cyclohexyl, cycloheptyl, cyclooctyl, etc.), branched-chain alkyl groups (e.g.,
isopropyl,
tert-butyl, sec-butyl, isobutyl, etc.), and alkyl-substituted alkyl groups
(e.g., alkyl-
substituted cycloalkyl groups and cycloalkyl-substituted alkyl groups).
Unless otherwise specified, the term "alkyl" includes both "unsubstituted
alkyls"
and "substituted alkyls." As used herein, the term "substituted alkyls" refers
to alkyl
groups having substituents replacing one or more hydrogens on one or more
carbons of the
hydrocarbon backbone. Such substituents may include, for example, alkenyl,
alkynyl,
halogeno, hydroxyl, alkylcarbonyloxy, arylcarbonyloxy, alkoxycarbonyloxy,
aryloxy,
aryloxycarbonyloxy, carboxylate, alkylcarbonyl, arylcarbonyl, alkoxycarbonyl,
aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkylthiocarbonyl,
alkoxyl,
phosphate, phosphonato, phosphinato, cyano, amino (including alkyl amino,
dialkylamino,
arylamino, diarylamino, and alkylarylamino), acylamino (including
alkylcarbonylamino,
arylcarbonylamino, carbamoyl and ureido), imino, sulfhydryl, alkylthio,
arylthio,
thiocarboxylate, sulfates, alkylsulfinyl, sulfonates, sulfamoyl, sulfonamido,
nitro,
trifluoromethyl, cyano, azido, heterocyclic, alkylaryl, or aromatic (including
heteroaromatic) groups.
In some embodiments, substituted alkyls can include a heterocyclic group. As
used
herein, the term "heterocyclic group" includes closed ring structures
analogous to
carbocyclic groups in which one or more of the carbon atoms in the ring is an
element
other than carbon, for example, nitrogen, sulfur or oxygen. Heterocyclic
groups may be
saturated or unsaturated. Exemplary heterocyclic groups include, but are not
limited to,
aziridine, ethylene oxide (epoxides, oxiranes), thiirane (episulfides),
dioxirane, azetidine,
oxetane, thietane, dioxetane, dithietane, dithiete, azolidine, pyrrolidine,
pyrroline, oxolane,
dihydrofuran, and furan.
5
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
The term "antibiotic," as used herein, refers to a substance well known to
skilled
artisans that controls the growth of bacteria, fungi, or similar
microorganisms, wherein the
substance can be a natural substance produced by bacteria or fungi, or a
chemically/biochemically synthesized substance (which may be an analog of a
natural
substance), or a chemically modified form of a natural substance.
The term "weight percent," "wt.%," "wt-%," "percent by weight," "% by weight,"
and variations thereof, as used herein, refer to the concentration of a
substance as the
weight of that substance divided by the total weight of the composition and
multiplied by
100.
As used herein, the term "cleaning" refers to a method used to facilitate or
aid in
soil removal, bleaching, microbial population reduction, and any combination
thereof As
used herein, the term "microorganism" refers to any noncellular or unicellular
(including
colonial) organism. Microorganisms include all prokaryotes. Microorganisms
include
bacteria (including cyanobacteria), spores, lichens, fungi, protozoa, virinos,
viroids,
viruses, phages, and some algae. As used herein, the term "microbe" is
synonymous with
microorganism.
As used herein, the term "disinfectant" refers to an agent that kills all
vegetative
cells including most recognized pathogenic microorganisms, using the procedure
described
in A.O.A.C. Use Dilution Methods, Official Methods of Analysis of the
Association of
Official Analytical Chemists, paragraph 955.14 and applicable sections, 15th
Edition, 1990
(EPA Guideline 91-2). As used herein, the term "high level disinfection" or
"high level
disinfectant" refers to a compound or composition that kills substantially all
organisms,
except high levels of bacterial spores, and is effected with a chemical
germicide cleared for
marketing as a sterilant by the Food and Drug Administration. As used herein,
the term
"intermediate-level disinfection" or "intermediate level disinfectant" refers
to a compound
or composition that kills mycobacteria, most viruses, and bacteria with a
chemical
germicide registered as a tuberculocide by the Environmental Protection Agency
(EPA).
As used herein, the term "low-level disinfection" or "low level disinfectant"
refers to a
compound or composition that kills some viruses and bacteria with a chemical
germicide
registered as a hospital disinfectant by the EPA.
As used herein, the term "medium chain" refers to medium to shorter long chain
carboxylic acid chains. While in some cases medium chain length can be defined
as C5-
6
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
C12, for purposes of this application, some shorter long chain carboxylic acid
chains will
be encompassed within the meaning of the term medium chain as used herein.
Specifically,
the term "medium chain" can encompass carboxylic acid chain lengths of between
C5 and
C22, preferably C5 and C18, more preferably C5 and C12. Chain lengths
exceeding 22
carbons are not considered medium chain for the purposes of this application.
As used herein, the term "microorganism" refers to any noncellular or
unicellular
(including colonial) organism. Microorganisms include all prokaryotes.
Microorganisms
include bacteria (including cyanobacteria), spores, lichens, fungi, protozoa,
virinos,
viroids, viruses, phages, and some algae. As used herein, the term "microbe"
is
synonymous with microorganism.
As used herein, the terms "mixed" or "mixture" when used relating to
"peroxycarboxylic acid composition" or "peroxycarboxylic acids" refer to a
composition
or mixture including more than one peroxycarboxylic acid, such as a
composition or
mixture including peroxyacetic acid (POAA) and peroxyoctanoic acid (POOA).
As used herein, the terms "peracid" or "peroxy acid" refer to an acid having
the
hydrogen of the hydroxyl group replaced by a hydroxy group. Oxidizing peracids
are
referred to herein as peroxycarboxylic acids.
As used herein the term "peracid forming composition" refers to a composition
that
produces a peracid when the components of the composition are combined. For
example,
in some embodiments, a peracid forming composition suitable for use in the
present
invention includes an organic acid and an oxidizing agent.
For the purpose of this patent application, successful microbial reduction is
achieved when the microbial populations are reduced by at least about 50%, or
by
significantly more than is achieved by a wash with water. Larger reductions in
microbial
population provide greater levels of protection.
As used herein, the terms "sanitizer," "sanitize," and the like refer to an
agent or
action that reduces the number of bacterial contaminants in a particular
location or source.
In an embodiment, sanitizers for use in this herein will provide at least a 3-
log reduction,
more preferably a 4-log reduction, most preferably a 5-log order reduction of
bacteria in a
particular location or source. Preferably, the compositions and methods can
meet the
BACS test for industrial water. Differentiation of antimicrobial "-cidal" or "-
static"
activity, the definitions which describe the degree of efficacy, and the
official laboratory
7
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
protocols for measuring this efficacy are considerations for understanding the
relevance of
antimicrobial agents and compositions. Antimicrobial compositions can affect
two kinds
of microbial cell damage. The first is a lethal, irreversible action resulting
in complete
microbial cell destruction or incapacitation. The second type of cell damage
is reversible,
.. such that if the organism is rendered free of the agent, it can again
multiply. The former is
termed microbiocidal and the later, microbistatic. According to embodiments of
the
compositions and methods disclosed herein, the compositions and methods can
provide in
some instances cidal activity, and preferably act as a sanitizer; however, in
other
embodiments, the compositions and methods provide microbistatic action.
As used herein, the term "substantially free" refers to compositions
completely
lacking the component or having such a small amount of the component that the
component does not affect the performance of the composition. The component
may be
present as an impurity or as a contaminant and shall be less than 0.5 wt-%. In
another
embodiment, the amount of the component is less than 0.1 wt-% and in yet
another
embodiment, the amount of component is less than 0.01 wt-%.
The term "substantially similar cleaning performance" refers generally to
achievement by a substitute cleaning product or substitute cleaning system of
generally the
same degree (or at least not a significantly lesser degree) of cleanliness or
with generally
the same expenditure (or at least not a significantly lesser expenditure) of
effort, or both.
As used herein, the term "sulfoperoxycarboxylic acid," "sulfonated peracid,"
or
"sulfonated peroxycarboxylic acid" refers to the peroxycarboxylic acid form of
a
sulfonated carboxylic acid. In some embodiments, the sulfonated peracids of
the present
invention are mid-chain sulfonated peracids. As used herein, the term "mid-
chain
sulfonated peracid" refers to a peracid compound that includes a sulfonate
group attached
.. to a carbon that is at least one carbon (e.g., the three position or
further) from the carbon of
the percarboxylic acid group in the carbon backbone of the percarboxylic acid
chain,
wherein the at least one carbon is not in the terminal position. As used
herein, the term
"terminal position," refers to the carbon on the carbon backbone chain of a
percarboxylic
acid that is furthest from the percarboxyl group.
As used herein, the term "waters" includes food process or transport waters.
Food
process or transport waters include produce transport waters (e.g., as found
in flumes, pipe
transports, cutters, slicers, blanchers, retort systems, washers, and the
like), belt sprays for
8
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
food transport lines, boot and hand-wash dip-pans, third-sink rinse waters,
and the like.
Waters also include domestic and recreational waters such as pools, spas,
recreational
flumes and water slides, fountains, and the like.
The methods, systems, apparatuses, and compositions of the present invention
may
comprise, consist essentially of, or consist of the components and ingredients
of the present
invention as well as other ingredients described herein. As used herein,
"consisting
essentially of' means that the methods, systems, apparatuses and compositions
may
include additional steps, components or ingredients, but only if the
additional steps,
components or ingredients do not materially alter the basic and novel
characteristics of the
claimed methods, systems, apparatuses, and compositions.
Compositions
According to an embodiment of the invention a medium chain peracid and
peracetic acid composition is employed for industrial and commercial water
systems,
namely to reduce and/or prevent biofilm growth. In an aspect, the compositions
according
to the invention may include one or more medium chain peracid or a medium
chain
sulfoperoxycarboxylic acid or mixture thereof
In a further aspect, the peracid composition can also include an organic acid
and an
oxidizing agent. In a still further aspect, the peracid composition can be a
peracid forming
composition. In various aspects, the peracid composition can be formed by an
organic acid
and an oxidizing agent. In other aspects, peracid forming compositions may be
employed
to generate a peracid composition in situ. Additional description of exemplary
in situ
methods for peracid forming compositions is provided in U.S. Patent Nos.
8,846,107 and
8,877,254, which are herein incorporated by reference in its entirety.
The concentration of peracids employed in a peracid composition according to
the
invention is suitable to replace standard water systems treatment compositions
(e.g.,
hypochlorite or bromide). In an aspect, the concentration of peracids is
sufficient to
sanitize a water system or portion thereof In a further aspect, the
concentration of peracids
is sufficient to control the problematic biofilms without reducing the process
or operation
of the water system.
In an aspect, peracid compositions are dosed based on the water system for
treatment. For example, concentrations of peracid compositions suitable for
use based on a
cooling tower will differ than concentration used based on a paper mill. In a
further aspect,
9
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
peracid compositions can be employed in a water system at a concentration up
to about 15
ppm. In another aspect, peracid compositions can be employed in the water
system at a
concentration between about 1 ppm and about 15 ppm. In an embodiment of the
invention,
the peracid compositions can be employed in the water system at a
concentration between
about 6 ppm and about 12 ppm for biofilm control. In an embodiment of the
invention, the
peracid compositions can be employed in the water system at a concentration
between
about 1 ppm and about 5 ppm for controlling solution bacteria. Thus, it should
be
understood that in particular embodiments where both solution bacteria and
biofilm control
are desired, a higher concentration (e.g., about 6 ppm to about 12 ppm) may be
employed
to remove biofilm. Subsequent to removal, the system may employ a lower
concentration
of prevention of bacterial growth in the water system.
In a preferred embodiment of the invention, the short chain peracid is in the
water
system at a concentration between about 1 ppm and about 14 ppm, more
preferably
between about 7 ppm and about 14 ppm. In a preferred embodiment of the
invention, the
medium chain peracid is in the water system at a concentration between about 1
ppm and
about 14 ppm, more preferably between about 2 ppm and about 5 ppm. Without
being
according to the invention, all ranges recited are inclusive of the numbers
defining the
range and include each integer within the defined range.
The pH of the compositions can vary depending on the water system that is
being
treated. However, it is generally expected that many, although not all, water
systems
treated with the compositions of the invention will have a pH between about 6
and about
10, more preferably a pH between about 7 and about 9.
Peroxycarboxylic Acids
Peroxycarboxylic (or percarboxylic) acids generally have the formula R(CO3H)n,
where, for example, R is an alkyl, arylalkyl, cycloalkyl, aromatic, or
heterocyclic group,
and n is one, two, or three, and named by prefixing the parent acid with
peroxy. The R
group can be saturated or unsaturated as well as substituted or unsubstituted.
Peroxycarboxylic acids can be made by the direct action of an oxidizing agent
on a
carboxylic acid, by autoxidation of aldehydes, or from acid chlorides, and
hydrides, or
carboxylic anhydrides with hydrogen or sodium peroxide.
Peroxycarboxylic acids may include short chain and/or medium chain
peroxycarboxylic acids. As used herein, a "short chain peracid" refers to a
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
peroxycarboxylic acid having a carbon chain between 1 and 4 carbons. As used
herein, the
phrase "medium chain peracid" refers to a peroxycarboxylic acid having a
carbon chain
between 5 and 22 carbons in length. Further as used herein, the phrase "medium
chain
carboxylic acid" can refer to a carboxylic acid that has a critical micellar
concentration
.. greater than 1 mM in aqueous buffers at neutral pH. It is also common for
medium chain
carboxylic acids to have a disfavorable odor. Medium chain carboxylic acids
exclude
carboxylic acids that are infinitely soluble in or miscible with water at 20
C. Medium chain
carboxylic acids include carboxylic acids with boiling points (at 760 mm Hg
pressure) of
180 to 300 C. In an embodiment, medium chain carboxylic acids include
carboxylic acids
.. with boiling points (at 760 mm Hg pressure) of 200 to 300 C. In an
embodiment, 20
medium chain carboxylic acids include those with solubility in water of less
than 1 g/L at
25 C. Examples of medium chain carboxylic acids include pentanoic acid,
hexanoic acid,
heptanoic acid, octanoic acid, nonanoic acid, decanoic acid, undecanoic acid,
and
dodecanoic acid. In one embodiment, the medium chain peroxycarboxylic acid
employed
within the compositions of the invention is a C5 to C22 peroxycarboxylic acid.
In a
preferred embodiment, a C5 to C18 peroxycarboxylic acid is employed in the
compositions
described herein. In a more preferred embodiment, a C5 to C12 peroxycarboxylic
acid is
employed in the compositions described herein.
As used herein, the phrase "short chain peroxycarboxylic acid" refers to the
.. peroxycarboxylic acid form of a short chain carboxylic acid (i.e., Cl to
C4). Short chain
peracids have the benefit of often being highly miscible in water at 25 C.
Examples of
short chain carboxylic acids include formic acid, acetic acid, propionic acid,
and butyric
acid. In some embodiments, the compositions and methods of the present
invention include
peroxyacetic acid or acetic acid. Peroxyacetic (or peracetic) acid is a
peroxycarboxylic acid
having the formula: CH3C000H. Generally, peroxyacetic acid is a liquid having
an acrid
odor at higher concentrations and is freely soluble in water, alcohol, ether,
and sulfuric
acid. Peroxyacetic acid can be prepared through any number of methods known to
those of
skill in the art including preparation from acetaldehyde and oxygen in the
presence of
cobalt acetate. A solution of peroxyacetic acid can be obtained by combining
acetic acid
with hydrogen peroxide. In a preferred embodiment, the compositions of the
invention
employ a Cl to C4 peroxycarboxylic acid.
11
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
Peroxycarboxylic acids useful in the compositions and methods of the present
invention include peroxyformic, peroxyacetic, peroxypropionic, peroxybutanoic,
peroxypentanoic, peroxyhexanoic, peroxyheptanoic, peroxyoctanoic,
peroxynonanoic,
peroxydecanoic, peroxyundecanoic, peroxydodecanoic, or the peroxyacids of
their
branched chain isomers, peroxylactic, peroxymaleic, peroxyascorbic,
peroxyhydroxyacetic,
peroxyoxalic, peroxymalonic, peroxysuccinic, peroxyglutaric, peroxyadipic,
peroxypimelic
and peroxysubric acid and mixtures thereof
In some embodiments, the compositions of the invention utilize a combination
of
several different peroxycarboxylic acids. For example, in some embodiments,
the
composition includes one or more Cl to C4 peroxycarboxylic acids and one or
more C5 to
C22 peroxycarboxylic acids. Especially preferred, is an embodiment in which a
Cl to C4
peroxycarboxylic acid and a C5 to C12 acid are utilized in combination. In a
preferred
embodiment, peroxyacetic acid and peroxyoctanoic acid are utilized in
combination. In one
aspect of the invention the ratio of short chain peracid to medium chain
peracid can be
about 2:1 to about 10:1, preferably from about 4:1 to about 8:1, more
preferably about 5:1
to about 7:1, and most preferably about 6:1.
In some embodiments, the compositions and methods of the present invention
include peroxyoctanoic acid. Peroxyoctanoic (or peroctanoic) acid is a
peroxycarboxylic
acid having the formula, for example, of n-peroxyoctanoic acid:
CH3(CH2)6C000H.
Peroxyoctanoic acid can be an acid with a straight chain alkyl moiety, an acid
with a
branched alkyl moiety, or a mixture thereof Peroxyoctanoic acid is surface
active and can
assist in wetting hydrophobic surfaces, such as those of microbes.
Peroxyoctanoic acid can
be prepared through any number of methods known to those of skill in the art.
A solution
of peroxyoctanoic acid can be obtained by combining octanoic acid and hydrogen
peroxide.
In an aspect of the invention a commercially-available peroxyoctanoic acid
containing product is available under the commercial name Octave (Ecolab,
Inc.).
Additional description of particularly suitable peroxyoctanoic acids is
disclosed in U.S.
Patent Nos. 7,498,051, 7,504 123, 7,507,429 and 7,569,232, which are herein
incorporated
by reference.
In a preferred aspect of the invention, the peracid includes a peracetic acid
and/or
acetic acid (organic acid source). There is an additional unexpected benefit
of employing a
12
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
peroxyoctanoic acid in combination with peracetic acid according to an
embodiment of the
invention. Interestingly, the addition of a medium chain peracid (e.g.
peroctanoic acid) to a
short chain peracid (e.g., peracetic acid) provides no benefit for microbial
kill in solution.
However, the combination of a short and medium chain peracid was surprisingly
found to
provide a significant benefit for the inhibition of bacteria growth on
surfaces in water
systems, i.e. biofilms.
In some embodiments, the compositions of the present invention include about 1
ppm to about 100 ppm of one or more peroxycarboxylic acids. In certain
embodiments of
the invention it may be preferred to provide a high concentration "shock
dose." Such a
shock dose can be between about 50 ppm and about 100 ppm of the one or more
peroxycarboxylic acid. In another embodiment of the invention it may be
desired to
regularly dose a smaller concentration to maintain prevention of bacteria
growth. Such a
dose can be between about 1 ppm and about 15 ppm. Dosage regimes that alter
between
occasional shock doses and regular smaller concentration dosages may be
employed. It is
to be understood that all values and ranges between these values and ranges
are
encompassed by the present invention.
Sulfoperoxycarboxylic Acids
The compositions and methods as described herein can optionally include the
use
of a sulfoperoxycarboxylic; however, it should be understood that the
compositions and
methods may also exclude sulfoperoxycarboxylic acids. Sulfoperoxycarboxylic
acids (or
sulfopercarboxylic) acids generally have the formula
R1-CH- -Cf.)001-1
SOIX
wherein RI is hydrogen, or a substituted or unsubstituted alkyl group; R2 is a
substituted or
unsubstituted alkyl group; X is hydrogen, a cationic group, or an ester
forming moiety; or
salts or esters thereof In some embodiments, RI is a substituted or
unsubstituted Cm alkyl
group; X is hydrogen a cationic group, or an ester forming moiety; R2 is a
substituted or
unsubstituted Cn alkyl group; m=1 to 10; n=1 to 10; and m+n is less than 18,
or salts, esters
or mixtures thereof In some embodiments, RI is hydrogen. In other embodiments,
RI is a
13
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
substituted or unsubstituted alkyl group. In some embodiments, Ri is a
substituted or
unsubstituted alkyl group that does not include a cyclic alkyl group.
In some embodiments, Ri is a substituted alkyl group. In some embodiments, Ri
is
an unsubstituted C1-C9 alkyl group. In some embodiments, Ri is an
unsubstituted C7 or Cs
alkyl. In other embodiments, Ri is a substituted C8 - Cm alkyl group.
In some embodiments, Ri is a substituted C8-C10 alkyl group is substituted
with at
least 1, or at least 2 hydroxyl groups. In still yet other embodiments, Ri is
a substituted Cl-
C9 alkyl group. In some embodiments, Ri is a substituted C1-C9 substituted
alkyl group is
substituted with at least 1 SO3H group.
In other embodiments, Riis a C9-C10 substituted alkyl group. In some
embodiments, Ri is a substituted C9-C10 alkyl group wherein at least two of
the carbons
on the carbon backbone form a heterocyclic group. In some embodiments, the
heterocyclic
group is an epoxide group.
In some embodiments, R2 is a substituted Cl to C10 alkyl group. In some
embodiments, R2is a substituted C8-C10 alkyl. In some embodiments, R2 is an
unsubstituted C6-C9 alkyl. In other embodiments, R2 is a C8 to C10 alkyl group
substituted
with at least one hydroxyl group. In some embodiments, R2 is a C10 alkyl group
substituted with at least two hydroxyl groups. In other embodiments, R2 is a
C8 alkyl group
substituted with at least one SO3H group. In some embodiments, R2 is a
substituted C9
group, wherein at least two of the carbons on the carbon backbone form a
heterocyclic
group. In some embodiments, the heterocyclic group is an epoxide group. In
some
embodiments, Ri is a C8-C9 substituted or unsubstituted alkyl, and R2 is a C7-
C8
substituted or unsubstituted alkyl.
Additional description of particularly suitable sulfoperoxycarboxylic acids is
disclosed in U.S. Patent No. 8,344,026 and U.S. Patent Application Serial Nos.
12/568,493
and 13/290,355 which are herein incorporated by reference in their entirety.
Without wishing to be bound by any particular theory, it is thought that mid-
chain
sulfonated peracids, e.g., mid-chain sulfonated peracids with a C10-C18 carbon
backbone
have a substantially greater solubility compared to terminally sulfonated
peracids of a
similar chain length, even at an acidic pH. For example, at a pH of 4, the
terminally
sulfonated peracid, 11-sulfoundecane peroxoic acid has a relatively low
solubility of about
1.3%. At the same pH, the mid chain sulfonated peracid, persulfonated oleic
acid has a
14
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
solubility of greater than about 50%. This is unexpected as an increase in
peracid chain
length is thought to lead to a decrease in solubility. The issue of low
solubility when using
long chain peracids has been addressed by increasing the pH to above 7.
However, at
increased pH antimicrobial efficacy is substantially reduced. Further,
bleaching efficacy
decreases proportionally with every pH unit increase over about 7. Thus,
solubility at an
acidic pH (lower than about 7) is beneficial to the mid-chain sulfonated
peracids of the
present invention.
In some embodiments, the compositions of the invention utilize a combination
of
several different sulfoperoxycarboxylic acids. For example, in some
embodiments, the
composition includes one or more Cl to C4 sulfoperoxycarboxylic acids and one
or more
C5 to C22 and more preferably C5 to C12 sulfoperoxycarboxylic acids.
The sulfoperoxyacids disclosed according to the invention can be formed using
a
variety of reaction mechanisms. For example, in some embodiments, the peracids
are
formed by the direct acid catalyzed equilibrium action of hydrogen peroxide
with the
starting materials.
Organic Acids
The peracid compositions may also include at least one organic acid. Any
organic
acid capable of forming a peracid can be used in the compositions and methods
of the
present invention. Suitable organic acids for use with the present invention
include, but are
not limited to, carboxylic acids.
In some embodiments, the compositions of the present invention include at
least
one carboxylic acid. In some embodiments, the compositions of the present
invention
include at least two, at least three, or at least four or more carboxylic
acids.
In some embodiments, the carboxylic acid for use with the compositions of the
present invention is a Cl to C22 carboxylic acid. In some embodiments, the
carboxylic
acid for use with the compositions of the present invention is a C5 to C12
carboxylic acid.
In some embodiments, the carboxylic acid for use with the compositions of the
present
invention is a Cl to C4 carboxylic acid. Examples of suitable carboxylic acids
include, but
are not limited to, formic, acetic, propionic, butanoic, pentanoic, hexanoic,
heptanoic,
octanoic, nonanoic, decanoic, undecanoic, dodecanoic, as well as their
branched isomers,
lactic, maleic, ascorbic, citric, hydroxyacetic, neopentanoic, neoheptanoic,
neodecanoic,
oxalic, malonic, succinic, glutaric, adipic, pimelic subric acid, and mixtures
thereof
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
In some embodiments, the compositions of the present invention include about
10
wt-% to about 95 wt-%, about 25 wt-% to about 80 wt-%, or about 50 wt-% to
about 75
wt-% of a carboxylic acid. In some embodiments, the compositions of the
present
invention include acetic acid. In other embodiments, the compositions of the
present
invention include octanoic acid. In other embodiments, the compositions of the
present
invention include a combination of octanoic acid and acetic acid.
Oxidizing Agent
The peracid compositions may also include an oxidizing agent. The oxidizing
agent
can be effective to convert an acid into a peracid. The oxidizing agent may
include a
peroxide source. Oxidizing agents suitable for use with the compositions
include the
following types of compounds or sources of these compounds, or alkali metal
salts
including these types of compounds, or forming an adduct therewith: hydrogen
peroxide,
urea-hydrogen peroxide complexes or hydrogen peroxide donors of: group 1 (IA)
oxidizing
agents, for example lithium peroxide, sodium peroxide; group 2 (IA) oxidizing
agents, for
example magnesium peroxide, calcium peroxide, strontium peroxide, barium
peroxide;
group 12 (JIB) oxidizing agents, for example zinc peroxide; group 13 (IIIA)
oxidizing
agents, for example boron compounds, such as perborates, for example sodium
perborate
hexahydrate of the formula Na2[B2(02)2(OH)41=6H20 (also called sodium
perborate
tetrahydrate); sodium peroxyborate tetrahydrate of the formula
Na2B2(02)2[(OH)41=4H20
(also called sodium perborate trihydrate); sodium peroxyborate of the formula
Na2[B2(02)2(OH)41 (also called sodium perborate monohydrate); group 14 (IVA)
oxidizing
agents, for example persilicates and peroxycarbonates, which are also called
percarbonates,
such as persilicates or peroxycarbonates of alkali metals; group 15 (VA)
oxidizing agents,
for example peroxynitrous acid and its salts; peroxyphosphoric acids and their
salts, for
example, perphosphates; group 16 (VIA) oxidizing agents, for example
peroxysulfuric
acids and their salts, such as peroxymonosulfuric and peroxydisulfuric acids,
and their
salts, such as persulfates, for example, sodium persulfate; and group VIIa
oxidizing agents
such as sodium periodate, potassium perchlorate. Other active inorganic oxygen
compounds can include transition metal peroxides; and other such peroxygen
compounds,
and mixtures thereof
In some embodiments, the compositions of the present invention employ one or
more of the inorganic oxidizing agents listed above. Suitable inorganic
oxidizing agents
16
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
include ozone, hydrogen peroxide, hydrogen peroxide adduct, group IIIA
oxidizing agent,
or hydrogen peroxide donors of group VIA oxidizing agent, group VA oxidizing
agent,
group VIIA oxidizing agent, or mixtures thereof Suitable examples of such
inorganic
oxidizing agents include percarbonate, perborate, persulfate, perphosphate,
persilicate, or
mixtures thereof
In some embodiments, the oxidizing agent includes hydrogen peroxide, or a
source
or donor of hydrogen peroxide. Hydrogen peroxide can be provided as a mixture
of
hydrogen peroxide and water, e.g., as liquid hydrogen peroxide in an aqueous
solution.
Hydrogen peroxide is commercially available at concentrations of 35%, 70%, and
90% in
water.
The compositions may contain an effective amount of an oxidizing agent. In
some
embodiments, the compositions include about 0.001 wt-% to about 60 wt-% of the
oxidizing agent, or about 1 wt-% to about 25 wt-% of the oxidizing agent. In
some
embodiments, the compositions include about 30 wt-% to about 50 wt-% of the
oxidizing
agent. It is to be understood that all ranges and values between these ranges
and values are
encompassed by the present invention.
Solubilizer
The present peracid compositions can include a solubilizer. The present
invention
relates to solubilizers for various peroxycarboxylic acids, including
preferably
peroxyoctanoic acid. In an embodiment, the solubilizer can increase or
maintain the
solubility in the composition. The present compositions and methods can
include any of a
variety of suitable solubilizers. For example, the solubilizer can include a
solvent, a
surfactant, or a mixture thereof as disclosed herein. Further description of
solubilizers
particularly well suited for use with peroxyoctanoic acid compositions is
found in U.S.
.. Patent Nos. 7,498,051 and 7,569,232, which are herein incorporated by
reference in their
entirety.
Solvent
In some embodiments, the peracid compositions of the present invention are
liquids. Therefore, in some embodiments, the compositions of the invention
further include
a solvent or solubilizer. In some embodiments, the solvent is water. The water
may be
provided by the use of aqueous reagents, viz, oxidizing agent. In other
embodiments, an
additional amount of water is added to the peracid compositions.
17
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
In some embodiments, the liquid composition according to the present invention
is
a composition including more than 10 wt-% water but less than 90 wt-%. The
amount of
water included in the liquid composition can be for example, less than about
80 wt-%, less
than about 70 wt-%, and less than about 60 wt-% by weight of the liquid
composition. In
some embodiments, the composition can contain water between about 5 wt-% and
about 50
wt-%, about 10 wt-% and about 40 wt-%, or about 30 wt-%. It is to be
understood that all
values and ranges between these values and ranges are encompassed by the
methods of the
present invention.
Alternatively, the compositions may be free of or substantially free of any
added
water. A non-aqueous solvent may also be used in the compositions. For
example, in some
embodiments, an alcohol is included as a solvent in the compositions. In some
embodiments, a liquid composition of the invention is substantially non-
aqueous (or
anhydrous) in character. The term "substantially non-aqueous" as used herein
means that
while very small amounts of water may be incorporated into such preferred
compositions,
the amount of water in the non-aqueous liquid detergent compositions of the
invention are
less than about 30 wt-% of the composition. In some embodiments, the water
content of the
non-aqueous compositions will include less than about 10 wt-% by weight.
The compositions may include an effective amount of solvent. In some
embodiments, the compositions may include about 10 wt-% to about 99 wt-% of a
solvent,
or about 20 wt-% to about 80 wt-% of a solvent. In other embodiments, the
compositions
may include more than about 30 wt-%, more than about 50 wt-%, more than about
60 wt-
% or more than 70% of a solvent. It is to be understood that all values and
ranges between
these values and ranges are encompassed by the present invention.
Additional Functional Ingredients
The peracid compositions may also include additional functional ingredients.
Additional functional ingredients suitable for use in the present compositions
include, but
are not limited to, scale inhibitors, corrosion inhibitors, anionic polymers,
stabilizing
agents, surfactants, acidulants, hydrotropes, dispersants, antimicrobial
agents (e.g.
hypochlorite, bromide and the like), solidification agent, aesthetic enhancing
agent (i.e.,
colorant (e.g., pigment), odorant, or perfume), wetting agents, defoaming
agents,
thickening or gelling agents, among any number of constituents which can be
added to the
composition. Such adjuvants can be preformulated with the peracid compositions
or added
18
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
to the compositions after formation, but prior to use. The compositions can
also contain
any number of other constituents as necessitated by the application, which are
known and
which can facilitate the activity of the present compositions.
Stabilizer
Stabilizers (also referred to as "stabilizing agents") are commonly added to
equilibrium peracid compositions to stabilize the peracid and hydrogen
peroxide and
prevent the decomposition of these constituents. Examples of stabilizing
agents may
include for example, surfactants, couplers, hydrotropes, acid catalysts and
the like that are
conventionally used in equilibrium peracid compositions to stabilize and
improve shelf life
of the composition. Further examples of stabilizing agents include, for
example, chelating
agents or sequestrants. Such sequestrants include, but are not limited to,
organic chelating
compounds that sequester metal ions in solution, particularly transition metal
ions. Such
sequestrants include organic amino- or hydroxy-polyphosphonic acid complexing
agents
(either in acid or soluble salt forms), carboxylic acids (e.g., polymeric
polycarboxylate),
.. hydroxycarboxylic acids, aminocarboxylic acids, or heterocyclic carboxylic
acids, e.g.,
pyridine-2,6-dicarboxylic acid (dipicolinic acid). Dipicolinic acid, 1-hydroxy
ethylidene-
1,1-diphosphonic acid (CH3C(P03H2)20H) (HEDP) are further example of
stabilizing
agents.
Additional examples of stabilizing agents commonly used in equilibrium
chemistry
.. to stabilize the peracid and hydrogen peroxide and/or prevent the premature
oxidation of
the composition include phosphonic acid or phosphonate salt. Phosphonic acids
and
phosphonate salts include HEDP; ethylenediamine tetrakis methylenephosphonic
acid
(EDTMP); diethylenetriamine pentakis methylenephosphonic acid (DTPMP);
cyclohexane-1,2-tetramethylene phosphonic acid; amino[tri(methylene phosphonic
acid)];
(ethylene diamine[tetra methylene-phosphonic acid)]; 2-phosphene butane-1,2,4-
tricarboxylic acid; or salts thereof, such as the alkali metal salts, ammonium
salts, or
alkyloyl amine salts, such as mono, di, or tetra-ethanolamine salts;
picolinic, dipicolinic
acid or mixtures thereof In some embodiments, organic phosphonates, e.g., HEDP
are
well known as used stabilizing agents.
Stabilizers can be added to the peracid composition. Preferably the stabilizer
is in
the peracid composition in a concentration of between about 100 ppm and about
5 wt. %.
19
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
Surfactant
In some embodiments, the peracid compositions of the present invention may
include a surfactant. Surfactants may be included as a solubilizer for the
peracid
compositions (e.g. microemulsion forming surfactant). Surfactants suitable for
use with the
compositions of the present invention include, but are not limited to, anionic
surfactants,
nonionic surfactants, cationic surfactants, amphoteric surfactants,
zwitterionic surfactants,
mixtures thereof, or the like.
The solubilizer can include a microemulsion forming surfactant. Suitable
microemulsion forming surfactants include anionic surfactants, cationic
surfactants,
amphoteric surfactants, zwitterionic surfactants, mixtures thereof, or the
like. Suitable
microemulsion forming surfactants include anionic surfactants, such as sulfate
surfactant,
sulfonate surfactant, phosphate surfactant (phosphate ester surfactant), and
carboxylate
surfactant, mixtures thereof, or the like.
Methods
The methods employing the peracid compositions according to the invention are
suitable for various applications in industrial or commercial water systems,
namely water
recirculating systems. For example, it is contemplated that the peracid
compositions are
suitable for system sanitation (e.g. tank/vessel sanitation).
According to an embodiment the invention, methods for reducing and/or
eliminating microbial populations in a water system are provided. In some
aspects, the
methods of treating microbial populations are effective for killing one or
more of the
pathogenic bacteria associated biofilm production and/or biofouling. Such
bacteria include
a wide variety of microorganisms, such as aerobic and anaerobic bacteria,
including Gram
positive and Gram negative bacteria, yeast, molds, bacterial spores, viruses,
etc.
In a preferred aspect of the invention, the peracid compositions and methods
of
employing the same for reducing and/or eliminating microbial populations in a
water
system maintain water system operations and performance. Water systems
according to the
invention include, but are not limited to, cooling systems, including, but not
limited to
cooling towers, cooling basins, and reactor cooling systems; food, beverage
and industrial
process waters; pulp and paper mill systems; brewery pasteurizers; sweetwater
systems; air
washer systems; oil field drilling fluids and muds; petroleum recovery
processes; industrial
lubricants; cutting fluids; heat transfer systems; gas scrubber systems; latex
systems; clay
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
and pigment systems; decorative fountains; water intake pipes; ballast water
tanks; and
ship reservoirs.
According to a further embodiment, methods for replacing conventional chemical
biocides in water system processes are provided. In an embodiment, the use of
a peracid
composition in the water system process is in combination with conventional
chemical
biocides.
The various methods of the invention include may comprise, consist of and/or
consist essentially of one or more of the following steps: sanitizing a water
system;
sanitizing one or more water system vessels, pipes and/or components
(including
downstream equipment employed for the water system); sanitizing a water source
or other
component with a peracid composition; and the like. In another embodiment of
the
invention, the steps may include adding a peracid composition to a water
system to provide
microbistatic effect. In some embodiments of the invention, the compositions
and methods
can provide both a sanitizing effect and a microbistatic effect.
In an aspect of the invention, a peracid composition is introduced into a
vessel or
system/apparatus employed for water systems to sanitize the surface against
unwanted
bacterial agents. The introduction of the peracid composition is employed for
hard surface
cleaning and sanitizing, which may include clean-in-place systems (CIP) and/or
clean-out-
of-place systems (COP). For water system processes, COP systems may include
for
example readily accessible systems including tanks/vessels, removable system
parts, and
the like. For water system processes, CIP systems may include the internal
components of
tanks, lines, pumps and other process equipment used for processing typically
liquid
product streams. Beneficially, the treatment of the various CIP and/or COP
portions of the
system are uniquely suited to the water systems which rely heavily on internal
recycling
water. Such internal recycling is well suited to the methods of the invention
employing
peracid compositions as these compositions that have sufficient longevity and
compatibility with the water system source/materials.
In a preferred aspect, the peracid composition is introduced (e.g. injected)
into a
water systems vessel (i.e. cooling tank). In a further aspect, the peracid
composition is
introduced upstream from a cooling tank. Such introduction may further be in
combination
with traditional cleaning and sanitation practices that are routinely
performed on the water
21
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
system tank. The introduction of a peracid composition upstream from a water
systems
tank may be combined without CIP and/or CIP systems described herein.
In a further aspect, the peracid composition (or a portion thereof) remains in
the
vessel or water system instead of being drained therefrom. The amount of
peracid
composition remaining in the vessel may vary according to the desired level of
sanitization
and dependent upon the stability of the peracid composition.
It is to be understood that the methods may employ an aqueous or non-aqueous
peracid composition. In addition, either a concentrate or use concentration of
the peracid
compositions can be applied to or brought into contact with an object by any
conventional
method or apparatus for applying an antimicrobial or cleaning compound to an
object, such
as disclosed for example in applications of use described in U.S. Patent No.
7,507,429,
which is herein incorporated by reference in its entirety. For example, the
object can be
wiped with, sprayed with, poured on, foamed on, and/or immersed in the
compositions, or
a use solution made from the compositions. The compositions can be sprayed,
foamed, or
wiped onto a surface; the compositions can be caused to flow over the surface,
or the
surface can be dipped into the compositions. These and other methods of
contacting an
object or a surface with the peracid composition are within the scope of the
invention.
Contacting can be manual or by machine.
The onsite production of the peracid composition is also included within the
scope
of the invention. Exemplary methods and/or apparatus for producing certain
peracid
compositions are disclosed for example in U.S. Patent Nos. 8,889,900,
8,858,895,
8,729,296, 8,846,107, 8,933,263 and 8,877,254, which are incorporated herein
by reference
in their entirety.
The methods may include the introduction of the peracid compositions at a
temperature in the range of about 4 C to 60 C. After introduction of the
peracid
composition, the peracid (e.g. solution) is held in the vessel and/ or
circulated throughout
the system for a time sufficient for sanitization (e.g., to kill undesirable
microorganisms).
The contact time can vary based upon the concentration of the peracid
compositions, method of applying the peracid compositions, temperature
conditions,
amount of soil, microorganisms or contamination on the surface or apparatus to
be treated,
or the like. In some aspects of the invention the peracid compositions may be
retained in
the water system. In some aspects of the invention, the exposure time can be
at least about
22
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
seconds, at least about 15 seconds, or more. In other embodiments, the
exposure time is
at least a few minutes to a few hours. After the surfaces have been sanitized
by means of
the peracid compositions, the solution may be removed (e.g. drained from the
system) or
retained (in whole or in part) in the system for additional sanitizing
benefit.
5 In some embodiments, the methods of the invention may further employ
pressure
and/or mechanical action with the application of the peracid composition. As
one of skill
in the art will appreciate, mechanical action may include for example,
agitation, rubbing,
brushing, etc. Agitation can be by physical scrubbing of the surface (e.g.
tank), through
the action of the spray solution under pressure, through sonication, or by
other methods.
Agitation increases the efficacy of the spray solution in killing micro-
organisms, perhaps
due to better exposure of the solution into the crevasses or small colonies
containing the
micro-organisms. The spray solution, before application, can also be heated to
a
temperature of about 15 to 20 C, for example, about 20 to 60 C to increase
efficacy.
As one of skill in the art will ascertain as being within the scope of the
invention,
the amount of peracid composition provided to a water system will vary based
upon a
number of factors. For example, the size, structural orientation, materials
employed
therein, contamination level of the system, and the like will affect the
amount (and/or
concentration) of peracid composition applied thereto. In some aspects,
hundreds of
gallons of peracid composition (e.g. solution) may be provided to a water
system. In other
aspects, thousands of gallons of peracid composition (e.g. solution) may be
provided to a
water system, including for CIP cleaning methods.
The commercial and industrial water systems to which the peracid compositions
may
be added to inhibit planktonic and sessile microorganism formation include
cooling waters;
food, beverage and industrial process waters; pulp and paper mill systems;
brewery
pasteurizers; sweetwater systems; air washer systems; oil field drilling
fluids and muds;
petroleum recovery processes; industrial lubricants; cutting fluids; heat
transfer systems;
gas scrubber systems; latex systems; clay and pigment systems; decorative
fountains; water
intake pipes; ballast water tanks; and ship reservoirs, among others.
All publications and patent applications in this specification are indicative
of the
level of ordinary skill in the art to which this invention pertains. All
publications and
patent applications are herein incorporated by reference to the same extent as
if each
23
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
individual publication or patent application was specifically and individually
indicated as
incorporated by reference.
EXAMPLES
Embodiments of the present invention are further defined in the following non-
limiting Examples. It should be understood that these Examples, while
indicating certain
embodiments of the invention, are given by way of illustration only. From the
above
discussion and these Examples, one skilled in the art can ascertain the
essential
characteristics of this invention, and without departing from the spirit and
scope thereof,
can make various changes and modifications of the embodiments of the invention
to adapt
it to various usages and conditions. Thus, various modifications of the
embodiments of the
invention, in addition to those shown and described herein, will be apparent
to those skilled
in the art from the foregoing description. Such modifications are also
intended to fall
within the scope of the appended claims.
A mixed bacterial population representative of industrial cooling towers was
grown
overnight in 10% tryptic soy broth (TSB) and this bacterial population was
diluted with a
test water source as described in the different examples below such that it
provided in an
amount to achieve a total bacterial population of about 6.5 log in each tested
water.
EXAMPLE 1
Antimicrobial Efficacy in Suspension
The traditional metric for biocide efficacy in industrial water systems is the
ability
of a composition to kill against a suspension of microbes within a bulk
solution. Therefore,
an experiment was performed to determine the bactericidal efficacy of a
composition
according to the present invention, as compared to a peracetic acid or
peroctanoic acid only
control. A phosphate buffered dilution water was used at a 1/10 dilution ratio
for diluting
the bacterial population. The diluted bacterial population was then added to
test water at a
ratio of 1:500 to achieve a bacterial population near 6.5 log in the test
water. Three
different peracid systems were tested and dosed at 2 ppm total peracid
concentration to the
test water source as described above. Composition A comprises a peroctanoic
acid (POOA)
only system. Composition B comprises peracetic acid (POAA) only system.
Composition
C comprises a mixed peracetic acid/peroctanoic acid system, where the ratio
between
24
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
peracids is 6:1 POAA:POOA. The peracid systems were dosed at time 0 at 35 C
with no
subsequent biocide redosing after the initial dose. The bacteria population
was measured at
multiple time intervals over the next 24 hours. The results of those
measurements are
provided in Table 1 demonstrating the antimicrobial properties of each
composition.
Table 1 - Bacterial Survivors on a log10 scale.
Time (min.) Untreated Composition A Composition B Composition C
Control
0 6.25 6.53 6.25 6.5
6.18 6.34 6.16 6.2
30 6.30 6.23 4.97 4.7
60 6.32 6.08 4.69 3.3
120 6.28 5.69 2.85 3.4
240 6.20 5.59 2.00 2.0
1440 6.41 6.87 2.00 2.3
As can be seen from this table, after 4 hours composition B was effective at
killing
everything down to the level of quantification, while the total bacterial
population within
10 the untreated control group remained constant. Note that the bacteria
populations were not
enumerated below 2 log survivors. Further, there was no regrowth observed
above the 2-
log threshold at the 24 hr. timepoint under treatment with composition B.
Composition A
had very little efficacy, with a maximum reduction seen of only 1 log with
clear regrowth
at 24 hrs. With composition A only providing little benefit on its own, it is
reasonable that
composition C would not show significant improvement over composition B. That
is the
case, composition C performed in a similar manner as composition B but did not
show an
improvement in microbial efficacy over composition B. Composition C still
reached
maximum kill at 4 hrs., but in contrast to composition B, there was some
regrowth seen at
24 hrs.
EXAMPLE 2
Biofilm Inhibition
In contrast to the testing of Example 1, where kill efficiency was measured,
here
the ability of biocides to inhibit biofilm growth on surfaces was assessed. It
was observed
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
in the laboratory that there are bacteria that can grow at water-air/water-
surface interfaces
despite of biocide treatment at certain concentrations. Moreover, it has been
reported
many times that biofilms and slimes do form in well-treated water systems.
These
observations suggested that the slime-forming bacterial sector is not well
understood or
controlled.
For this study, the same phosphate buffered diluted bacterial population
source as
utilized in Example 1 was used. That diluted population was added to water
from two
different power plants to achieve a bacterial population near 6.5 log for
testing; the ratio of
diluted bacterial population to test water was about 1:500. The water obtained
from the
.. power plants was more alkaline at time 0 compared to the laboratory water
and was not
buffered. The first water source was a power plant cooling basin, referred to
as Power Plant
A throughout this example. The water source in Power Plant A had a starting pH
of 8.4,
limited turbidity and a natural bacterial population of 104. This slightly
alkaline pH
allowed the pH to drop after the addition of the acidic peracids systems. The
Power Plant A
water also contained more organic contaminants, i.e. total suspended solids
than the lab
water tested in Example 1; this led to turbidity and could potentially lead to
more
consumption of the biocides.
The peracids (compositions B or C) were added at concentration intervals of 3
ppm,
i.e. 3, 6, 9, 12 and 15 ppm. At the completion of the test the biofilms were
stained with a
.. dye. The intensity of the color directly correlates with dye uptake into
the biofilm and is a
measure of biofilm growth. No color was an indication that no biofilm was
present, i.e. that
the growth was fully inhibited. The ability of each composition to inhibit
biofilm formation
is shown below in Table 2.
Table 2 - Biofilm inhibition in Power Plant A (starting at pH 8.4)
Concentration (ppm)
Some Growth Full Inhibition pH range
Composition B 9 12 7.0-7.7
Composition C 3 6 7.5-8.0
As can be seen, a mixed peracid system (composition C) is between 2-3x better
at
biofilm inhibition than composition B (POAA only). It should also be pointed
out that
typically peracids have more microbial efficacy at lower pH. Composition B is
more acidic
26
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
than composition C and thus lowers the pH further from the 8.4 starting point.
The benefit
to the mixed peracid system is even more striking when considering it doesn't
have the
presumed advantage of less alkaline pH.
This result was verified with a second different industrial water source Power
Plant
B, which had a starting pH of 8.65 and visible suspended dirt, i.e., a higher
turbidity than
the water source in Power Plant A, which was already higher than the lab
water. Similar to
the water source in the power plant A, this industrial water source had a
natural bacterial
population of 104. Thus, the phosphate buffered diluted bacterial population
was added to
the water source from Power Plant B to achieve a bacterial population of near
6.5 log; the
ratio of diluted bacterial population to test water was again about 1:1500.
The results for
the testing of the water source from Power Plant B are shown below in Table 3.
Table 3 - Biofilm inhibition in Power Plant B (starting pH 8.65)
Concentration (ppm)
Compositions Some Growth Full Inhibition pH range
Composition B 9 12 7.8 at 6
ppm
Composition C 3 6 8.1 at 6
ppm
Despite the more alkaline pH and the increased level of impurities, the
biofilm
inhibition results were exactly the same in this second water source.
Composition C (mixed
peracid system) was again 2-3x better at biofilm inhibition than composition B
(POAA
only system).
Overall, this biofilm inhibition result is surprising since composition C had
almost
no impact on bacteria kill in solution. Yet it is clear the addition of a
medium-chain, more
hydrophobic peracid provides synergistic benefit to inhibit biofilm growth on
surfaces.
Without wishing to be bound by theory, this is likely due to the increased
surface attraction
the less water soluble peracid has. Therefore, this effect should be
replicated by any
sparingly water soluble organic peracid.
The inventions being thus described, it will be obvious that the same may be
varied
in many ways. Such variations are not to be regarded as a departure from the
spirit and
27
CA 03076370 2020-03-18
WO 2019/060814
PCT/US2018/052398
scope of the inventions and all such modifications are intended to be included
within the
scope of the following claims.
The above specification provides a description of the manufacture and use of
the
disclosed compositions and methods. Since many embodiments can be made without
departing from the spirit and scope of the invention, the invention resides in
the claims.
28
